EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Estimation of the epidemiological burden of HPV-related anogenital cancers, precancerous lesions, and genital warts in women and men in Europe: Potential additional benefit of a nine-valent second generation HPV vaccine compared to first generation HPV vaccines

Susanne Hartwig, Jean-Jacques Baldauf, Géraldine Dominiak-Felden, François Simondon, Laia Alemany, Silvia de Sanjosé, Xavier Castellsagué

Papillomavirus Research · 2015

DOI: 10.1016/j.pvr.2015.06.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Papillomavirus Research, 2015. Verfasst von Susanne Hartwig und 6 weiteren Autor:innen. Die Arbeit wurde bisher 83-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Hartwig, S., Baldauf, J., Dominiak-Felden, G., Simondon, F., Alemany, L., Sanjosé, S. D., & Castellsagué, X. (2015). Estimation of the epidemiological burden of HPV-related anogenital cancers, precancerous lesions, and genital warts in women and men in Europe: Potential additional benefit of a nine-valent second generation HPV vaccine compared to first generation HPV vaccines. Papillomavirus Research. https://doi.org/10.1016/j.pvr.2015.06.003

Vancouver

Hartwig S, Baldauf J, Dominiak-Felden G, Simondon F, Alemany L, Sanjosé SD, et al. Estimation of the epidemiological burden of HPV-related anogenital cancers, precancerous lesions, and genital warts in women and men in Europe: Potential additional benefit of a nine-valent second generation HPV vaccine compared to first generation HPV vaccines. Papillomavirus Research. 2015. doi:10.1016/j.pvr.2015.06.003

BibTeX
@article{Hartwig2015,
  author = {Hartwig, Susanne and Baldauf, Jean-Jacques and Dominiak-Felden, Géraldine and Simondon, François and Alemany, Laia and Sanjosé, Silvia de and Castellsagué, Xavier},
  title = {Estimation of the epidemiological burden of HPV-related anogenital cancers, precancerous lesions, and genital warts in women and men in Europe: Potential additional benefit of a nine-valent second generation HPV vaccine compared to first generation HPV vaccines},
  journal = {Papillomavirus Research},
  year = {2015},
  doi = {10.1016/j.pvr.2015.06.003}
}
Kostenlos starten →